Description
CV70 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity in vitro, inhibiting the activation of JNK and ERK5.
CV70 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity in vitro, inhibiting the activation of JNK and ERK5.
Purity | ≥70% |
---|---|
Formula | C16H14N2O4 |
Formula Wt. | 298.29 |
Appearance | Red Powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet | |
Brochures |
Pipaón C, Gutierrez P, Montero JC, et al. Mitogen-activated protein kinase routes as targets in the action of diaza-anthracene compounds with a potent growth-inhibitory effect on cancer cells. Mol Cancer Ther. 2002 Aug;1(10):811-9. PMID: 12492114.
p110α PI3K inhibitor.
Polypeptide; peptidoglycan inhibitor.
Steroid; glucocorticoid agonist.
Mycotoxin produced by Aspergillus; BK K+ channe...
Stable salt form of hyperforin, a compound foun...
GHB agonist, D2/3 antagonist.
LRRK2 inhibitor.
Nitroimidazole, binds DNA; nucleic acid synthes...
Antimicrobial peptide found in bee and wasp ven...
Vinca alkaloid found in Catharanthus; microtubu...
Mycotoxin produced by species of Aspergillus; D...
LRRK2 inhibitor.
beta-Amyloid anti-oligomer and aggregation inhi...
Neurotoxin found in puffer fish; site 1 voltage...
N-acetyl cysteine conjugate of phenethylisothio...
Curcumin derivative; DNMT1 and α-amylase inhib...
Cannabinoid receptor 2 selective agonist.
Thiopurine antimetabolite; PRPP amidotransferas...
Naturally sourced ITC, sulfonyl analog of sulfo...
EZH2 HMT inhibitor.